Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2008-09-12FDA Approved: HYDRALAZINE HYDROCHLORIDE — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' Hydralazine Hydrochloride under an Original Application (ANDA).
-
FDA approval · 2008-09-10FDA Approved: PROPRANOLOL HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for propranolol hydrochloride from Hikma Pharmaceuticals USA Inc., indicating regulatory approval of…
-
FDA approval · 2008-08-29FDA Approved: ATENOLOL — Supplemental Application (Zydus Lifesciences Limited)
The FDA approved a supplemental application for Atenolol from Zydus Lifesciences Limited under the ANDA.
-
CLINICAL_TRIALS trial_result · 2008-08-29Clinical Trial Update: Additive Beneficial Effects of Atorvastatin Combined With Amlodipine In Treatment of Hypertension [Phase 4]
Phase 4 clinical trial reports additive beneficial effects when combining atorvastatin with amlodipine for hypertension.
-
CLINICAL_TRIALS trial_result · 2008-08-27Clinical Trial Update: The Effects of Cilnidipine on Metabolic Syndrome Improvement [Phase 4]
Phase 4 clinical trial update examining cilnidipine for improvement of metabolic syndrome in hypertensive patients has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2008-08-22FDA Approved: LISINOPRIL — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.(780779901))
FDA approved a supplemental application for lisinopril from Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. to market a generi…
-
FDA approval · 2008-08-22FDA Approved: BENAZEPRIL HYDROCHLORIDE — Supplemental Application (Solco healthcare U.S., LLC)
The FDA granted supplemental approval for a benazepril hydrochloride product (Solco Healthcare U.S., LLC), a generic ACE inhibitor used to m…
-
FDA approval · 2008-08-22FDA Approved: CARVEDILOL — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for CARVEDILOL from Dr. Reddy's Laboratories Limited, authorizing its generic carvedilol product for…
-
CLINICAL_TRIALS trial_result · 2008-08-22Clinical Trial Update: Safety and Efficacy of Valsartan Plus Hydrochlorothiazide and Amlodipine in Hypertensive Patients [Phase 4]
Phase 4 trial evaluating the safety and efficacy of triple therapy with valsartan, hydrochlorothiazide, and amlodipine in patients with hype…
-
CLINICAL_TRIALS trial_result · 2008-08-19Clinical Trial Update: High Blood Pressure Strategy (HBPS) [NA]
This document provides a clinical trial update on the High Blood Pressure Strategy (HBPS) for hypertension, but the trial status is unknown.
-
FDA approval · 2008-08-18FDA Approved: BENAZEPRIL HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Benazepril hydrochloride from Aurobindo Pharma Limited.
-
FDA approval · 2008-08-15FDA Approved: HYDROCHLOROTHIAZIDE — Original Application (Exelan Pharmaceuticals Inc.)
The FDA approved Exelan Pharmaceuticals Inc.'s original application for hydrochlorothiazide, a generic diuretic indicated for hypertension a…
-
FDA label_change · 2008-08-14FDA Approved: ENALAPRIL MALEATE — Supplemental Application (Amici Pharma, Inc)
FDA approved a supplemental application for enalapril maleate from Amici Pharma, Inc., resulting in labeling changes for the product.
-
CLINICAL_TRIALS trial_result · 2008-08-14Clinical Trial Update: Milk Types and Fish Oil in 9- to 12-Month-Old Infants [NA]
This completed trial evaluated the effects of different milk types and fish oil supplementation in 9- to 12-month-old infants and potential …
-
CLINICAL_TRIALS research · 2008-08-12Clinical Trial Update: Ocsaar and CYP2C9 Ploymorphism, Is There a Connection Between Pharmacokinetics, Pharmacodynamics and Pharmacogenetics? [NA]
This clinical trial update examines whether CYP2C9 polymorphism affects pharmacokinetics and pharmacodynamics in hypertension, based on a st…
-
CLINICAL_TRIALS trial_result · 2008-08-08Clinical Trial Update: Effect of Amlodipine Monotherapy or Combined With Terazosin on Lower Urinary Tract Symptoms and Hypertension [NA]
A completed clinical trial evaluated amlodipine as monotherapy or in combination with terazosin for lower urinary tract symptoms and hyperte…
-
FDA approval · 2008-08-07FDA Approved: AZOR — Supplemental Application (Cosette Pharmaceuticals, Inc.)
FDA approved a supplemental application for AZOR (amlodipine besylate and olmesartan medoxomil) from Cosette Pharmaceuticals, Inc. AZOR is a…
-
CLINICAL_TRIALS trial_result · 2008-08-06Clinical Trial Update: The Efficacy, Safety and Genetic Polymorphism of Hypoca and Adalat OROS in Hypertensive Patients
A completed clinical trial evaluating the efficacy, safety and genetic polymorphism of Hypoca and Adalat OROS in hypertensive patients.
-
FDA approval · 2008-08-01FDA Approved: CLEVIPREX — Original Application (Fresenius Kabi Austria GmbH)
FDA approved CLEVIPREX (clevidipine) from Fresenius Kabi Austria GmbH in an Original Application (NDA022156) for short-term intravenous mana…
-
FDA label_change · 2008-07-31FDA Approved: DIOVAN HCT — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for Diovan HCT (valsartan/hydrochlorothiazide) submitted by Novartis, reflecting a labeling update f…
-
FDA approval · 2008-07-31FDA Approved: CARDENE IV — Supplemental Application (Baxter Healthcare Corporation)
The FDA approved Baxter Healthcare's supplemental application for Cardene IV (nicardipine hydrochloride), adding an intravenous formulation …
-
FDA approval · 2008-07-31FDA Approved: LISINOPRIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for the lisinopril and hydrochlorothiazide combination from Actavis Pharma, Inc. The approval covers…
-
CLINICAL_TRIALS research · 2008-07-30Clinical Trial Update: The Effect of Acupuncture on Blood Pressure and Heart Rate Variability (HRV) [Phase 1, Phase 2]
This update describes a Phase 1/2 clinical trial evaluating whether acupuncture affects blood pressure and heart rate variability in hyperte…
-
FDA approval · 2008-07-24FDA Approved: LOPRESSOR — Supplemental Application (Validus Pharmaceuticals LLC)
The FDA approved a supplemental application for Lopressor (metoprolol tartrate) from Validus Pharmaceuticals LLC.
-
CLINICAL_TRIALS trial_result · 2008-07-24Clinical Trial Update: Stress Reduction & CVD Morbidity and Mortality in Blacks [Phase 2]
Phase 2 clinical trial evaluating whether a stress reduction program reduces cardiovascular morbidity and mortality in Black participants.